Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.46 USD | -1.61% | +3.64% | -19.78% |
May. 09 | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
May. 09 | Transcript : Intellia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 68.47M | Sales 2025 * | 63.87M | Capitalization | 2.36B |
---|---|---|---|---|---|
Net income 2024 * | -490M | Net income 2025 * | -515M | EV / Sales 2024 * | 26.2 x |
Net cash position 2024 * | 567M | Net cash position 2025 * | 509M | EV / Sales 2025 * | 29 x |
P/E ratio 2024 * |
-4.75
x | P/E ratio 2025 * |
-4.76
x | Employees | 526 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.76% |
Latest transcript on Intellia Therapeutics, Inc.
1 day | -1.61% | ||
1 week | +3.64% | ||
Current month | +14.30% | ||
1 month | +0.78% | ||
3 months | -17.39% | ||
6 months | +1.37% | ||
Current year | -19.78% |
Managers | Title | Age | Since |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 18-10-28 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 19-01-23 |
John Leonard
CEO | Chief Executive Officer | 66 | 14-06-30 |
Frank Verwiel
CHM | Chairman | 62 | 17-07-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.15% | 2 M€ | -25.75% | ||
4.87% | 0 M€ | 0.00% | - | |
4.17% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 24.46 | -1.61% | 2,042,656 |
24-05-09 | 24.86 | +8.09% | 1,669,933 |
24-05-08 | 23 | -3.69% | 1,375,019 |
24-05-07 | 23.88 | +0.67% | 1,096,319 |
24-05-06 | 23.72 | +0.51% | 1,495,293 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.78% | 2.36B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NTLA Stock